[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349846-105":59,"doc-detail-349846-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nadcdb-a-joint-transcriptomic-database-for-non-aids-defining-cancer-research-in-hiv-positive-individuals","NADCdb - A Joint Transcriptomic Database for Non-AIDS-Defining Cancer Research in HIV-Positive Individuals","","Non-AIDS-defining cancers (NADCs) are a major cause of non-AIDS-related morbidity and mortality among people living with HIV (PLWH), yet limited clinical samples and privacy constraints hinder pathological and clinical progress. A joint analysis integrated transcriptomic data from 12,486 PLWH and cancer patients to identify candidate key regulators for 23 NADCs, resulting in NADCdb. The rNADC module risk-stratifies 21 NADCs using bidirectional stepwise regression with logistic modeling. The dNADC module uses Random Forest and Conditional Inference Trees to uncover pathogenic drivers, while iPredict identifies 1905 immune biomarkers across 16 NADCs.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nadcdb-a-joint-transcriptomic-database-for-non-aids-defining-cancer-research-in-hiv-positive-individuals/349846/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nadcdb-a-joint-transcriptomic-database-for-non-aids-defining-cancer-research-in-hiv-positive-individuals/349846.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does NADCdb address in non-AIDS-defining cancer research?","Question",{"text":112,"@type":113},"NADCdb targets the shortage of NADC clinical samples and the barriers created by privacy and security constraints, by integrating transcriptomic data from PLWH and cancer patients to enable systematic exploration of NADC pathology.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the rNADC module estimate risks for NADCs?",{"text":117,"@type":113},"The rNADC module performs risk assessment by prioritizing genes with aberrant expression trajectories, using bidirectional stepwise regression combined with logistic modeling to stratify risks for 21 NADCs.",{"name":119,"@type":110,"acceptedAnswer":120},"What roles do the dNADC and iPredict modules play?",{"text":121,"@type":113},"The dNADC module combines patients’ dysregulated genes with regulatory networks and uses Random Forest and Conditional Inference Trees to identify pathogenic drivers. The iPredict module identifies 1905 key immune biomarkers for 16 NADCs based on patients’ distinct immune states.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349846,1790180663,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nNADCdb: A Joint Transcriptomic Database for Non-AIDS-Defining Cancer Research in HIV-Positive Individuals  \nJiajia Xuan †, Chunhua Xiao†, Runhao Luo, Yonglei Luo, Qing-Yu He * and Wanting Liu *  \nAcademic Editor: Albrecht Reichle  \nReceived: 16 November 2025  \nRevised: 11 January 2026  \nAccepted: 20 January 2026  \nPublished: 23 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nMOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology,  \nJinan University, Guangzhou 510632, China; [xuanjj@jnu.edu.cn](xuanjj@jnu.edu.cn) (J.X.); [xch2023@stu.jnu.edu.cn](xch2023@stu.jnu.edu.cn) (C.X.);  \n[luorunhao@stu2022.jnu.edu.cn](luorunhao@stu2022.jnu.edu.cn) (R.L.); [yonglei1115@stu.jnu.edu.cn](yonglei1115@stu.jnu.edu.cn) (Y.L.)  \n* Correspondence: [tqyhe@jnu.edu.cn](tqyhe@jnu.edu.cn) (Q.-Y.H.); [wtliu@jnu.edu.cn](wtliu@jnu.edu.cn) (W.L.)† These authors contributed equally to this work.  \nAbstract  \nNon-AIDS-defining cancers (NADCs) have emerged as an increasingly prominent cause of non-AIDS-related morbidity and mortality among people living with HIV (PLWH) . However, the scarcity of NADC clinical samples, compounded by privacy and security constraints, continues to present formidable obstacles to advancing pathological and clinical investigations. In this study, we adopted a joint analysis strategy and deeply integrated and analyzed transcriptomic data from 12,486 PLWH and cancer patients to systematically identify potential key regulators for 23 NADCs. This effort culminated in NADCdb—a database specifically engineered for NADC pathological exploration, structured around three mechanistic frameworks rooted in the interplay of immunosuppression, chronic inflammation, carcinogenic viral infections, and HIVderived oncogenic pathways. The “rNADC” module performed risk assessment by prioritizing genes with aberrant expression trajectories, deploying bidirectional stepwise regression coupled with logistic modeling to stratify the risks for 21 NADCs. The “dNADC” module, synergized patients’ dysregulated genes with their regulatory networks, using Random Forest (RF) and Conditional Inference Trees (CITs) to identify pathogenic drivers of NADCs, with an accuracy exceeding 75%(in the external validation cohort, the prediction accuracy of the HIV-associated clear cell renal cell carcinoma model exceeded 90%) . Meanwhile,“iPredict” identified 1905 key immune biomarkers for 16 NADCs based on the distinct immune statuses of patients. Importantly, we conducted multi-dimensional profiling of these key determinants, including in-depth functional annotations, phenotype correlations, protein–protein interaction (PPI) networks, TF-miRNA-target regulatory networks, and drug prediction, to deeply dissect their mechanistic roles in NADC pathogenesis. In summary, NADCdb serves asa novel, centralized resource that integrates data and provides analytical frameworks, offering fresh perspectives and a valuable platform for the scientific exploration of NADCs.  \nKeywords: non-AIDS-defining cancer (NADC); people living with HIV (PLWH); cancer; biomarkers; joint analysis strategy  \n1. Introduction  \nHIV remains one of the most pressing global public health challenges, significantly compromising the health and quality of life of people living with HIV (PLWH) [1] . According to The Joint United Nations Programme on HIV/AIDS, approximately 40.8 million individuals were living with HIV by the end of 2024 [2] . Since the first reported case of HIV-1 infection, certain malignancies—termed AIDS-defining cancers (ADCs)—have been predominantly associated with PLWH, including Kaposi’s sarcoma, non-Hodgkin’s lymphoma, and primary central nervous system lymphom","cbCaiayzqqUV0skr","https://ap.wps.com/l/cbCaiayzqqUV0skr","pdf",5999025,24,"English","# Introduction\n## Background on HIV and NADCs\n## Proposed mechanisms for NADCs\n# Methods and database overview\n## Joint transcriptomic analysis\n## Modules: rNADC, dNADC, and iPredict\n## Multi-dimensional profiling and drug prediction\n# Conclusion","[{\"question\":\"What problem does NADCdb address in non-AIDS-defining cancer research?\",\"answer\":\"NADCdb targets the shortage of NADC clinical samples and the barriers created by privacy and security constraints, by integrating transcriptomic data from PLWH and cancer patients to enable systematic exploration of NADC pathology.\"},{\"question\":\"How does the rNADC module estimate risks for NADCs?\",\"answer\":\"The rNADC module performs risk assessment by prioritizing genes with aberrant expression trajectories, using bidirectional stepwise regression combined with logistic modeling to stratify risks for 21 NADCs.\"},{\"question\":\"What roles do the dNADC and iPredict modules play?\",\"answer\":\"The dNADC module combines patients’ dysregulated genes with regulatory networks and uses Random Forest and Conditional Inference Trees to identify pathogenic drivers. The iPredict module identifies 1905 key immune biomarkers for 16 NADCs based on patients’ distinct immune states.\"}]","NADCdb - A Joint Transcriptomic Database for Non-AIDS-Defining Cancer Research in HIV-Positive Individuals | PDF",1790085954,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7cf68c3ca3cd561e202ebc6f2698082.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afbe534b573b455373deb9582fd08250.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db727a13b78028416c4b12fd40757a9a.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/beb3c3660b6e84f2df7c0eb226cfd1f6.webp",980,1385]